A detailed history of Oddo Bhf Asset Management Sas transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Oddo Bhf Asset Management Sas holds 185,000 shares of BPMC stock, worth $24 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
185,000
Holding current value
$24 Million
% of portfolio
0.93%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$79.22 - $128.4 $14.7 Million - $23.8 Million
185,000 New
185,000 $23.7 Billion

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $7.73B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Oddo Bhf Asset Management Sas Portfolio

Follow Oddo Bhf Asset Management Sas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oddo Bhf Asset Management Sas, based on Form 13F filings with the SEC.

News

Stay updated on Oddo Bhf Asset Management Sas with notifications on news.